ANTX
NASDAQ · Pharmaceuticals
An2 Therapeutics Inc
$4.83
-0.13 (-2.62%)
Open$5.00
Previous Close$4.96
Day High$5.05
Day Low$4.70
52W High$7.19
52W Low$1.00
Volume—
Avg Volume184.3K
Market Cap187.55M
P/E Ratio—
EPS$-1.07
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+284.1% upside
Current
$4.83
$4.83
Target
$18.55
$18.55
$11.23
$18.55 avg
$22.80
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.24M | 7.98M | 7.65M |
| Net Income | 1.80M | 1.81M | 1.71M |
| Profit Margin | 21.9% | 22.7% | 22.3% |
| EBITDA | 3.67M | 3.33M | 3.32M |
| Free Cash Flow | 1.39M | 970.9K | 896.1K |
| Rev Growth | -4.4% | +17.2% | +22.3% |
| Debt/Equity | 1.44 | 1.37 | 1.29 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |